Delivery Order SPE2DB24D3014-SPE2DB25FKTTK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,048.07. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,026.00. The contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,766.20. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,059.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL KwikPen 3mL insulin pens, with an ultimate completion date of July 23, 2025. This non-set-aside competitive award represents a single delivery order transaction for pharmaceutical supplies to support federal medical procurement needs, with performance executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,243.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens. This is a non-set-aside contract with an ultimate completion date of August 20, 2025, and performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply transaction supporting military and federal healthcare systems'...
- The Defense Logistics Agency awarded a $1,059.72 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of June 20, 2025. This firm fixed-price contract is unclassified as a set-aside and represents a direct competitive award to the pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.09 to AmerisourceBergen Drug Corp for the supply of Humalog 200 Unit/ML KwikPen 3ML insulin pens. The contract employs firm fixed-price pricing with no set-aside designation, indicating it was awarded through open competition. The award was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.72 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $39,260.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award was issued on September 18, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the broader federal pharmaceutical supply chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens with a ceiling value of $5,887.90. This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-compete, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTTKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL KwikPen 3mL insulin pens with a ceiling value of $1,161.14. This non-set-aside contract is priced on a firm fixed price basis and represents a purchase of insulin medication for military healthcare programs. The award was made on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems globally. The firm fixed pricing structure and relatively short performance timeline reflect the operational nature of this transaction within the broader pharmaceutical support vehicle designed to ensure consistent availability of critical medical commodities across the Department of Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/18/25 |